12:00 AM
 | 
Dec 16, 2013
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Cytomegalovirus: Phase II started

Astellas began a double-blind, placebo-controlled, international Phase II trial to evaluate intramuscular ASP0113 in about 140 CMV-seronegative subjects receiving a kidney from a CMV-seropositive donor. ASP0113 is in a Phase III trial to prevent CMV reactivation in...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >